Human CD1d molecules present an unknown ligand, mimicked by the synthetic glycosphingolipid ␣-galactosylceramide (␣GC), to a highly conserved NKT cell subset expressing an invariant TCR V␣24-J␣Q paired with V␤11 chain (V␣24 ؉ V␤11 ؉ invariant NK T cell (NKT inv )). The developmental pathway of V␣24 ؉ V␤11 ؉ NKT inv is still unclear, but recent studies in mice were consistent with a TCR instructive, rather than a stochastic, model of differentiation. Using CD1d-␣GC-tetramers, we demonstrate that in humans, TCR variable domains other than V␣24 and V␤11 can mediate specific recognition of CD1d-␣GC. In contrast to V␣24 ؉ V␤11 ؉ NKT inv cells, V␣24 ؊ /CD1d-␣GC-specific T cells express either CD8␣␤ or CD4 molecules, but they are never CD4 CD8 double negative. We show that CD8␣␤ ؉ V␣24 ؊ /CD1d-␣GC-specific T cells exhibit CD8-dependent specific cytotoxicity and have lower affinity TCRs than V␣24
T he non-MHC encoded, ␤ 2 -microglobulin-associated CD1 molecules present glycolipids and phospholipids to T lymphocytes (1). According to their amino acid sequence homology, the four CD1 isoforms expressed in humans segregate into two groups. In group 1, CD1 molecules containing CD1a, CD1b, and CD1c are expressed in humans, but they are absent in mice and rats (2) . In contrast, the group 2 CD1 molecule, CD1d, is highly conserved in all mammals studied so far (3) . Group 1 CD1-molecules present either endogenous or microbial glycolipids to T lymphocytes expressing diverse TCR␣-and ␤-chains, including various V and J segments (4) . In contrast, the major human CD1d-restricted T lymphocyte subset so far identified expresses an invariant TCR V␣24-J␣Q chain paired with V␤11 and recognizes the synthetic, marine sponge-derived glycolipid ␣-galactosylceramide (␣GC) 4 (1, 5) . The great majority of these V␣24 ϩ V␤11 ϩ T cells coexpress the NK locus-encoded C type lectin NKR-P1 (CD161) and therefore are often referred to as invariant NK T cells (NKT inv ) (1) . The murine counterpart of human V␣24 ϩ V␤11 ϩ NKT inv cells expresses NKR-P1C (NK1.1) and recognizes the CD1d-␣GC complex through an invariant TCR V␣14-J␣281 chain in association with a restricted family of polyclonal V␤ domains (6) . All CD1d-␣GC-specific NKT inv cells so far described are either CD4 ϩ , CD8␣␣ ϩ , or CD4 Ϫ CD8 Ϫ double negative (DN), while CD8␣␤
ϩ NKT inv cells have never been described, and are thought to be deleted during ontogeny due to their high binding avidity to CD1d molecules (7) . NKT inv cells are capable of rapidly secreting large amounts of regulatory cytokines, such as IL-4 and IFN-␥. Consistent with a regulatory role of NKT inv cells in vivo, development of various autoimmune diseases in mice and humans has been associated with a decrease in the frequency of peripheral NKT inv cells (8 -10) . Several lines of evidence have recently been generated which suggest that NKT inv cells derive from common mainstream precursor thymocytes, rather than from separate precursor cells committed to this lineage before variable gene rearrangement. First, the pairing of the invariant V␣-chain with a particular V␤-chain is not forced by molecular constraint (11) ; and second, the unused TCR␣ and ␥ loci of NKT inv cells are indistinguishable from those of mainstream T cells (12, 13) . Therefore, the driving force for the selection of these cells may not be genetic programming, but rather Ag specificity. In agreement with a mainstream precursor (or TCR instructive) model, it has recently been suggested that mouse NKT inv cells go through a CD4 ϩ CD8 ϩ double positive stage during thymocyte development (14) .
We reasoned that if Ag-driven selection was responsible for in vivo expansion of NKT inv cells, then a broad CD1d-␣GC-specific TCR repertoire should be generated by random rearrangement. Using recombinant human CD1d-tetramers loaded with ␣GC, we tested this hypothesis and investigated whether V␣24
Ϫ /CD1d-␣GC-specific T cells could be expanded in vitro upon stimulation of human PBMC with ␣-GC. Our results unambiguously demonstrate the existence of human V␣24
Ϫ /CD1d-␣GC-specific T cells using a wide variety of TCR V␣-and V␤-chains. Unlike conventional NKT inv cells, V␣24-independent CD1d-␣GC-specific T cell populations only rarely express CD161, and are either CD4 ϩ or CD8␣␤ ϩ .
Materials and Methods

Generation of DC
PBMC were purified from healthy donors' buffy coat by layering over Lymphoprep (Nycomed, Asker, Norway). Monocytes were then positively selected using magnetic beads coated with anti-CD14 mAbs (MACS; Miltenyi Biotec, Bergisch Gladbach, Germany). The monocyte-depleted lymphocyte fraction (CD14-negative) was frozen until needed. Monocytes were cultured in cell growth medium (RPMI 1640, Sigma-Aldrich, Dorset, U.K.; 10% FCS, 2 mM L-glutamine; Life Technologies, Paisley, U.K.; 1 mM nonessential amino acids, 1 mM sodium pyruvate, 55 M 2-ME, penicillin G, and streptomycin; Life Technologies, Paisley, U.K.), containing 50 ng/ml GM-CSF (Novartis, Basel, Switzerland) and 1000 U/ml IL-4 (15) . The monocytes were plated in 6-well costar plates at 4 ϫ 10 5 cells/ml (3 ml/well). After 4 days, maturation was induced in some wells by adding either bacterial LPS (final concentration 1 g/ml LPS of Salmonella abortus equi; Sigma-Aldrich), 50 ng rTNF-␣ (R&D Systems, Minneapolis, MN), or 4 ϫ 10 4 irradiated (6 Gy) CD40L-expressing B cells (16) . Immature and matured monocyte-derived dendritic cells (Mo-DC) were used for phenotypic analysis and in vitro priming after 6 days in culture, i.e., 40 h after induction of maturation.
T cell in vitro stimulation
Monocyte-depleted or total PBMC were plated in 24-wells at 1 ϫ 10 6 cells/ml in cell growth medium. The following culturing conditions were chosen: 1) Freshly isolated or thawed PBMC (2 ϫ 10 6 ) from a single donor, cultured in the presence of 100 nM ␣GC (KRN7000; Kirin Brewery, Gumna, Japan); 2) Coculture of 2 ϫ 10 6 monocyte-depleted, thawed lymphoctes and 2 ϫ 10 5 autologous, ␣GC-pulsed immature or matured Mo-DC, respectively. For pulsing of Mo-DC with ␣GC, cells were cultured for 2 h in 24-wells in a volume of 200 l RPMI 1640 containing 1 M ␣GC, followed by addition of 2 ϫ 10 6 lymphocytes in 1.8 ml of the above medium (i.e., 100 nM final ␣GC concentration). After 5 days, IL-2 was added to cultures (25 IU/ml). Thereafter, cultures were fed every 3-4 days with fresh medium containing IL-2 (1000 U/ml).
Flow cytometry
The following Abs and tetramers were used to stain single-cell suspensions of Mo-DC and in vitro stimulated T cell cultures: purified anti-CD86 (BD Pharmingen, San Diego, CA), -CD83 (Immunotech, Marseille, France), -MHC-class II (mAb L243; American Type Culture Collection, Manassas, VA), -MHC-class I (mAb W6/32; American Type Culture Collection), and PE-conjugated goat-anti-mouse pan IgG (Southern Biotechnology Associates, Birmingham, AL); allophycocyanin-and PE-conjugated human CD1d tetramers loaded with either ␣GC or ␣-mannosylceramide (␣MC) were generated as previously described (17); FITC-and PE-anti-human TCR V␣24, FITC anti-human TCR V␤11 (Serotec, Oxford, U.K.), FITCanti-CD3, -CD4, -CD8␣, PE-anti-CD4 (all from DAKO, Kobenhavn, Denmark), FITC-anti-CD161, PerCP-anti-CD8␣, allophycocyanin-anti-CD8␣, -CD3 (all from BD Pharmingen), FITC-anti-TCR V␤1, -V␤9, -V␤12, -V␤16, -V␤18, -V␤23, and PE-anti-CD8␤ (all from Immunotech). Cells were stained on ice for 30 min, washed twice in ice-cold PBS/1% FCS, and directly analyzed. In some experiments (Fig. 4a) , cells were first stained with anti-TCR V␤ Abs, followed by CD1d-tetramers. In monomer competition experiments (Fig. 4b) , cells were first incubated with CD1d-␣GC monomers for 20 min at room temperature before addition of CD1d-␣GC tetramers on ice for another 30 min. Propidium iodide was used to gate out dead cells. For monomer-binding and chase studies (Fig. 9a) , cells were first incubated on ice with CD1d-␣GC monomers for 30 min, washed twice in ice-cold PBS, stained with R-PE-Extraavidin (Sigma-Aldrich) on ice for 30 min, and washed twice with ice-cold PBS. Then, cells were either centrifuged and immediately fixed using 4% formaldehyde in PBS (chase time "0 min") or incubated at 37°C 5% CO 2 in a volume of 200 l PBS for different chase periods (15, 30 , and 60 min) before fixation. Samples were analyzed on a FACSCalibur flow cytometer, and data were processed using CellQuest software (BD Biosciences, San Jose, CA).
Cell sorting and generation of V␣24
Ϫ /CD1d-␣GC-tetramer ϩ cell lines 
Chromium release assays
TCR V␣24-positive and -negative lines and clones were used as effector cells in a 5-h 51 Cr release assay 14 days after restimulation. Human CD1d-expressing C1R cells (C1R-CD1d) were used as target cells. C1R-CD1d were labeled for 90 min with 51 Cr and at the same time pulsed with either 1 M ␣GC, 1 M ␣MC, or vehicle, followed by extensive washing in warm RPMI 1640. In CD8-blocking experiments, cells were cultured in the presence of the CD8-blocking Ab, MF8 (18) , or an irrelevant isotypematched control Ab at 1/100, 1/500, and 1/1000 dilution of ascites. Cells were cultured in triplicate in 96-well round bottom microtiter plates. E:T ratios were 1:1, 3:1, and 9:1. Maximum release was determined from supernatants of cells that were lysed by addition of 5% Triton X-100, and spontaneous release was determined from target cells incubated without effector cells. Percent specific lysis was expressed as (cpm of sample Ϫ cpm of spontaneous release)/(cpm of maximum release Ϫ cpm of spontaneous release). Anti-CD8-mediated inhibition of specific lysis by D5.1 and D6.1 ( 
Intracellular cytokine staining
A total of 2.5 ϫ 10 5 T lymphocytes were cultured in 48-well plates in the presence of either glycolipid-pulsed C1R-CD1d (see Materials and Methods) or 10 Ϫ7 M PMA (Sigma-Aldrich) and 1 g/ml ionomycin (SigmaAldrich). After 90 min, 10 g/ml brefeldin A (Sigma-Aldrich) was added to the cultures to block cytokine secretion. After 6 h in culture, cells were washed twice in PBS and fixed in 2% paraformaldehyde. Intracellular cytokine staining was performed after permeabilization of cells with FACS permeabilization buffer (BD Biosciences), using the following Abs from BD Pharmingen: FITC-anti-IFN-␥, PE-anti-IL-4, PE-anti-IL-13, and allophycocyanin-anti-IL-2. Four-color analysis was performed on a FACSCalibur flow cytometer (BD Biosciences).
Spectratyping of TCR repertoire
Total RNA was extracted from a pure TCR V␣24
Ϫ /CD1d-␣GC-tetramer ϩ polyclonal cell line (see Materials and Methods) using RNAzol reagent according to the manufacturer's instruction, and sscDNA was synthesized by reverse transcription using Moloney murine leukemia virus reverse transcriptase and an oligo(dT) adaptor in a reaction volume of 50 l.
Oligonucleotides used to analyze the 32 different TCR V␣ and 24 different TCR V␤ families, as well as the C␣-and C␤-specific primers, have been described (19, 20) . Each TCR V␣-and TCR V␤-PCR product was then used as a template for extension, or run-off, reactions using C␣-and C␤-specific nested fluorescent primers, respectively. The fluorescent run-off products were subjected to gel electrophoresis in an automated DNA sequencer (PerkinElmer, Bucks, U.K.), and CDR3 size distribution and signal intensities were analyzed with GeneScan software (PerkinElmer). Analysis of V␤-joining (J␤) segments was conducted in the same way using previously described fluorescent J␤-specific oligonucleotide probes (20) .
Results
Expansion of CD1d-␣GC-specific V␣24-negative T cells in vitro from healthy donors' PBMC
We and others have recently demonstrated that CD1d-tetramers loaded with ␣GC can be used for sensitive detection of human and mouse CD1d-␣GC-specific NKT inv cells (17, 21, 22) . Among freshly isolated PBMC from healthy donors, the frequency of V␣24 ϩ V␤11 ϩ NKT inv cells ranges from 0.01 to 1.0%. The frequency of V␣24-negative/CD3
ϩ cells binding to CD1d-␣GC-tetramer in fresh PBMC samples from healthy donors was very low, and could not be confidently distinguished from background staining (data not shown). In contrast, distinct TCR V␣24-negative T cells stained by CD1d-␣GC-tetramers (V␣24 Ϫ /CD1d-␣GC-tetramer ϩ T cells) could be expanded in vitro from all seven donors tested, to frequencies ranging from 1.0 to 5.5% (Fig. 1 , and data not shown). The percentage of V␣24 Ϫ /CD1d-␣GC-tetramer ϩ T cells varied significantly with different stimulation protocols. Interestingly, stimulation with ␣GC-pulsed mature autologous Mo-DC was required for efficient expansion of V␣24 Ϫ /CD1d-␣GC-tetramer ϩ T cells in some donors (Fig. 1, a-c) , while addition of ␣GC alone (without Mo-DC) was sufficient to visibly expand V␣24
Ϫ /CD1d-␣GC-tetramer ϩ T cells in other subjects (Fig.  1d) . In all donors, we observed a greater expansion of V␣24 Ϫ / CD1d-␣GC-tetramer ϩ cells when mature, rather than immature, ␣GC-pulsed Mo-DC were used for stimulation ( Fig. 1 and data (6) . For these reasons, it has been speculated that the V␤-chain does not contribute to the specific recognition of CD1d-␣GC (21). When we compared staining of ␣GC-stimulated in vitro cultures with CD1d-␣GC-tetramers and Abs against TCR V␣24 or V␤11, we found that in all seven donors, a substantial proportion of V␣24 Ϫ /CD1d-␣GC-specific T cells expressed V␤11 (Fig. 2) . In some donors, V␣24
Ϫ V␤11 ϩ / CD1d-␣GC-tetramer ϩ cells comprised Ͼ90% of all V␣24 Ϫ / CD1d-␣GC-specific T cells (data not shown).
To determine the usage of TCR V␣-and V␤-chains of V␣24
Ϫ / CD1d-␣GC-specific T cells, we subjected a polyclonal V␣24
Ϫ / CD1d-␣GC-tetramer ϩ line (Fig. 3a) to spectratype analysis (Fig.  3, b and c) . Fig. 3c shows TCR V␣ families, TCR V␤ families, and J␤ segments identified by spectratype analysis of this V␣24
Ϫ / CD1d-␣GC-specific line. Prominent expansions for seven different TCR V␣-families (AV2, AV6, AV8, AV15, AV20, AV23, and AV26) and seven different TCR V␤-families (BV1, BV3, BV9, BV11, BV12, BV18, and BV23) with different CDR3 lengths, also within the same family (BV3), were found in this donor (supplementary data showing expansions of V␣ and V␤ families are appended).
Guided by the results of the spectratype analysis, we then screened five V␣24
Ϫ /CD1d-␣GC-tetramer ϩ oligoclonal lines and one V␣24
Ϫ /CD1d-␣GC-tetramer ϩ clone obtained from the same donor, with anti-TCR V␤-Abs. Consistent with the results from the spectratype analysis, three lines expressed TCR V␤1, and two lines and the clone were TCR V␤11-positive (data not shown). Ϫ /CD1d-␣GC-specific T cells express TCR V␤11. PBMC from donor 1 were cocultured with LPS-matured, ␣GC-pulsed Mo-DC. Stainings were conducted with a, CD1d-␣GC-tetramers and either V␣24-specific Abs; or b, A mixture of V␣24-and V␤11-specific Abs. Percentages (on day 16 of the T cell culture) are shown for V␣24
ϩ /CD1d-␣GC-tetramer
, and CD1d-␣GC-tetramer ϩ / (V␣24 V␤11) ϩ T cells (b). All density plots were gated on propidium iodide negative, CD3 ϩ lymphocytes.
Preincubation of a pure V␤1 ϩ line with an anti-V␤1-specific mAb, but not with an anti-TCR V␤11 Ab, significantly reduced staining by CD1d-␣GC tetramers (Fig. 4a) . Likewise, preincubation of an oligoclonal, V␤1 ϩ and V␤11 ϩ line with anti-V␤11 Ab selectively reduced tetramer staining of V␤11 ϩ cells (data not shown). These results formally demonstrated that staining of these V␣24 Ϫ T cell lines by CD1d-␣GC tetramers was due to tetramer-binding to the TCR, rather than to other receptors. Consistent with these results, CD1d-␣GC tetramer-staining of V␣24 Ϫ /CD1d-␣GC tetramer ϩ T cell lines could be partially blocked by preincubation with an excess of CD1d-␣GC monomers (Fig. 4b) .
Taken together, these results demonstrate that ␣GC not only stimulates V␣24 ϩ V␤11 ϩ NKT inv lymphocytes, but can also efficiently induce a CD1d-␣GC-specific polyclonal, V␣24-independent T cell response. TCR V␤11 is overrepresented among V␣24 Ϫ /CD1d-␣GC-specific T cells, suggesting either an inherent affinity of V␤11 to CD1d or its direct involvement in specific recognition of CD1d-␣GC.
Functional capacities of V␣24 Ϫ /CD1d-␣GC-specific T lymphocytes
To further assess Ag specificity of V␣24 Ϫ /CD1d-␣GC-tetramer ϩ T lymphocytes, we studied their capacity to specifically lyse CD1d-transfected C1R cells (C1R-CD1d) pulsed with ␣GC, ␣MC, or vehicle (Fig. 5) . These results demonstrated that both CD4 ϩ and CD8␣␤ ϩ V␣24 Ϫ /CD1d-␣GC-tetramer ϩ T cells are highly efficient in specifically lysing ␣GC-pulsed, but not unpulsed or ␣MC-pulsed, C1R-CD1d (Fig. 5 ). In the same experiment, levels of specific lysis were similar for V␣24
Ϫ /CD1d-␣GC-tetramer ϩ T cells and V␣24 ϩ V␤11 ϩ NKT inv (data not shown). To determine the potential of cytokine production, V␣24 ϩ
V␤11
ϩ NKT inv and V␣24 Ϫ /CD1d-␣GC-specific T cell lines were stimulated with either glycolipid-pulsed C1R-CD1d or PMA and ionomycin. Fig. 6 shows the results of the CD4 ϩ V␣24 Ϫ /CD1d-␣GC-specific T cell line 2c, which secreted IL-2 (data not shown) and IFN-␥, as well as IL-13 and IL-4. Other V␣24 Ϫ /CD1d-␣GC-specific lines produced mainly IL-2, IFN-␥, and IL-13, but not IL-4, while the V␣24 Ϫ /CD1d-␣GC-specific clone 2A, which specifically killed ␣GC-pulsed C1R-CD1d (Fig. 5) , did not secrete IFN-␥. In contrast, all tested V␣24 ϩ V␤11 ϩ NKT inv lines produced IL-2, IFN-␥, IL-4, and IL-13 (data not shown), as it has been previously shown by others (1). These results suggested that V␣24 Ϫ /CD1d-␣GC-specific T cells have the potential to produce a broad range of different cytokine profiles.
CD4/CD8-coreceptor use and CD161-expression in V␣24
Ϫ /CD1d-␣GC-specific T cells
Mouse and human NKT inv cells are either CD4 ϩ CD8 Ϫ or CD4 Ϫ CD8 Ϫ (DN), whereas to date no CD8␣␤-expressing ␣GC-specific NKT inv cells have been described (1, 24) . We observed that a significant proportion of V␣24 Ϫ /CD1d-␣GC-specific T cells in several donors were CD8␣␤ ϩ CD4 Ϫ (Fig. 7) , while all other V␣24
Ϫ /CD1d-␣GC-specific T cells were CD4 ϩ CD8 Ϫ (data not shown). In contrast, DN V␣24
Ϫ /CD1d-␣GC-specific T cells were not found in any of the seven donors analyzed (data not shown). To investigate the role of CD8 in V␣24
Ϫ /CD1d-␣GC-specific T cell lines, we assessed whether lysis of ␣GC-pulsed C1R-CD1d cells by CD8␣␤
ϩ V␣24 Ϫ cells could be inhibited by the presence of an anti-CD8 blocking Ab (18) . The results of these experiments showed that incubation with anti-CD8 blocking Ab, but not with an irrelevant isotype-matched control Ab, significantly reduced specific lysis of ␣GC-pulsed C1R-CD1d cells (Fig. 8) .
Although the great majority of ␣GC-specific mouse and human NKT inv cells express CD161 (or NKR-P1), an NK-locus-encoded C-type lectin, it has been reported that CD161 is down-regulated after in vitro stimulation with anti-CD3 Ab (25) . In contrast, another study described the expression of CD161 by a large proportion of V␣24-JaQ ϩ V␤11 ϩ cells upon stimulation of PBMC with ␣GC-pulsed Mo-Dc (26) . We compared expression of CD161 on V␣24
Ϫ and V␣24 ϩ CD1d-␣GC-specific T cells from the same culture, 2 wk after stimulation with ␣GC. At this time point, CD161 was expressed on the majority of V␣24 ϩ V␤11 ϩ NKT inv cells, but it was detected only on a small minority of CD4 ϩ CD8␣␤ Ϫ V␣24 Ϫ CD1d-␣GC ϩ -tetramer positive cells (Fig. 7) . CD161 was virtually absent on CD8␣␤ ϩ V␣24 Ϫ CD1d-␣GC ϩ -tetramer positive cells (Fig. 7 and data not shown) . CD1d-␣GC-specific T cell clones and lines (Fig. 9a and data not shown) . As a control, we showed that CD3 expression levels and intensity of tetramer-staining for CD8␣␤ ϩ V␣24 Ϫ and DN Va24 ϩ CD1d-␣GC-specific cells were identical (Fig. 9b and data not shown) . Monomeric CD1d-␣GC complexes were capable of staining a large fraction of the DN V␣24 ϩ
V␤11
ϩ line and dissociated with a half-life of ϳ50 min (Fig. 9a and data 
Discussion
The glycolipid-presenting CD1d molecule is highly conserved among mammalian species and exhibits distinct cross-specific recognition by conserved DN or CD4 ϩ lymphocyte subsets coexpressing an invariant TCR V␣24-J␣Q segment paired to V␤11 and CD161 (NKR-P1) (3). These NKT inv specifically recognize the marine-sponge-derived, synthetic glycolipid ␣GC, while the natural ligand seen by these cells in vivo remains unknown (5).
Recent evidence from mouse studies indicates that NKT inv cells do not develop from separate precursor cells committed to this sublineage before variable-gene rearrangement, but branch off the mainstream developmental pathway because of their TCR specificity (11) (12) (13) (14) . Therefore, we reasoned that recognition of CD1d-␣GC may not be uniformly restricted to NKT inv cells bearing the canonical TCR V␣24-J␣Q chain, but may also be mediated by other randomly generated TCRs.
We and others have recently described the use of rCD1d-tetramers loaded with ␣GC for sensitive and specific identification of both murine invariant V␣14-J␣281 ϩ or human V␣24 ϩ V␤11 ϩ NKT inv cells (17, 21, 22) . Using different in vitro culture conditions in combination with the use of human CD1d-␣GC-tetramers, we tested the hypothesis that human T lymphocytes, other than the "conventional" CD161 ϩ V␣24 ϩ V␤11 ϩ NKT inv subset, can recognize CD1d-bound ␣GC. Distinct V␣24-negative T cell populations binding to CD1d-␣GC-tetramers were detected in all seven healthy donors' PBMC after in vitro stimulation with ␣GC-pulsed matured Mo-DC (Fig.  1) . In two donors, addition of ␣GC alone (without Mo-DC) was sufficient to visibly expand V␣24 Ϫ /CD1d-␣GC-specific T cells (Fig. 1d and data not shown) , suggesting that these cells were expanded in vivo, albeit at a frequency below the threshold required for tetramer staining. Specificity of these novel T cell subsets for CD1d-␣GC complex was demonstrated in several ways. First, V␣24
Ϫ /CD1d-␣GC tetramer ϩ lines and clones specifically lysed ␣GC-pulsed, but not unpulsed or ␣MC-pulsed C1R-CD1d cells, ruling out ligand-independent recognition of CD1d (Fig. 5) . Second, addition of monomeric CD1d-␣GC complexes efficiently prevented staining by CD1d-␣GC tetramers (Fig. 4b) . Finally, preincubation with TCR-specific Abs significantly reduced specific staining by CD1d-␣GC tetramers (Fig. 4a) .
Consistent with a mainstream model of NKT inv cell selection, spectratype analysis demonstrated that V␣24
Ϫ /CD1d-␣GC-specific T cells can use a wide variety of V␣ and V␤ segments (Fig.  3) . However, a marked bias was observed for the use of V␤11 (Fig.  2 and data not shown), with Ͼ90% of V␣24 Ϫ /CD1d-␣GC-specifc T cells using V␤11 in some donors (data not shown). Previous tetramer-based analysis of NKT inv cells in mice have suggested that the CDR3␤ regions are permissive, but do not specifically contribute to the recognition of CD1d-␣GC complexes (21) . Similar to the observation that some V␤ regions have inherent affinity for MHC class II molecules (27) , human V␤11 regions may have inherent affinity for CD1d molecules. Alternatively, the V␤11 regions in V␣24
Ϫ /CD1d-␣GC-specifc T cells may contribute more specifically to the recognition of CD1d-␣GC complexes.
"Conventional" NKT inv in humans and mice exhibit a CD4 ϩ or a DN phenotype (1) . In contrast, all Va24 Ϫ /CD1d-␣GC-specific T cells in our seven donors were either CD4 ϩ or CD8␣␤ ϩ , but they were never DN (Fig. 7 and data not shown) . Importantly, specific lysis of ␣GC-pulsed CD1d-expressing targets by CD8␣␤ ϩ V␣␤24 Ϫ / CD1d-␣GC-specific lines was significantly reduced in the presence of an anti-CD8 blocking Ab (Fig. 8) , demonstrating that CD8␣␤ can act as a coreceptor for human glycolipid-specific CD1d-restricted T cells.
Previous studies in mice have provided evidence that CD1d binds CD8 and not CD4 (7, 11, 12) . Lantz and Bendelac (11) have shown that in V␣14-J␣281-transgenic mice, the CD8-compartment is selectively depleted of V␤7 and V␤8, i.e., the main V␤-chains used by mouse V␣14-J␣281 NKT inv cells. The same group found that V␣14-J␣281 NKT inv were lost in CD8 transgenic mice, suggesting that CD8␣␤-expressing NKT inv cells are negatively selected during thymic development due to excessive avidity (12) . This model predicts that NKT inv cells bear TCRs with a high inherent affinity for CD1d loaded with either ␣GC or its natural "␣GC-like" ligand. Our observation that monomeric CD1d-␣GC complex can efficiently bind to DN NKT inv cells, but not to CD8␣␤ ϩ V␣24 Ϫ CD1d-specific T cells (Fig. 9a) is highly consistent with such a model. In addition, it has been previously demonstrated that higher affinities of the TCR-peptide/MHC interaction favor the development of a CD4 ϩ phenotype, whereas lower affinities result in a CD8 ϩ phenotype (28, 29) , and that TCR binding energetics can determine the expression of NKR-P1 by NKT inv cells (30 -32) . Among V␣24 Ϫ /CD1d-␣GC-specific T cell subsets in the subjects we studied, CD161 was rarely expressed on CD4 ϩ cells (data not shown), and was absent from CD8␣␤ ϩ cells (Fig. 7) .
Based on these results, we hypothesize that in humans, a wide variety of CD1d-␣GC-specific TCRs are generated by random TCR rearrangement, and that the binding affinity of a given TCRCD1d/␣GC interaction is a key determinant in CD4/CD8␣␤/DN lineage commitment and CD161 expression. The fact that V␣24 Ϫ / CD1d-␣GC-specific T cells can express CD8␣␤ and exhibit CD8-dependent cytotoxicity (Figs. 7 and 8 ) is consistent with a lower affinity TCR for CD1d-␣GC in these CD8␣␤
ϩ cells compared with conventional CD8␣␤ Ϫ V␣24 ϩ /V␤11 NKT inv cells, and the clear difference in CD1d-␣GC monomer staining between CD8␣␤ ϩ and DN V␣24 ϩ CD1d-specific T cells (Fig. 9a ) supports this hypothesis.
Hence, it is possible that higher surface density of CD1d loaded with ␣-GC (or its natural ligand) may be required for expansion of V␣24 Ϫ /CD1d-␣GC-specific T cells compared with NKT inv . Although the identity of the ␣-GC-like natural ligand is not known, it is tempting to speculate that conditions associated with an increased synthesis of the "␣-GC-like" natural ligand in vivo may lead to the expansion of V␣24 Ϫ /CD1d-␣GC-specific T cells. Likewise, injection of ␣GC in vivo for therapeutic reasons may induce expansion of V␣24 Ϫ /CD1d-␣GC-specific T cells. Phase I clinical trials, investigating the safety profile of weekly i.v. ␣GC injections in patients with solid malignant tumors are currently underway (33) . Based on our findings, it is possible that CD4 ϩ and CD8
ϩ Va24 Ϫ /CD1d-␣GC-specific T cells expand in a proportion of patients receiving ␣GC. Because the in vivo function of these cells is still unknown, we suggest that tetramer-based monitoring of V␣24
Ϫ /CD1d-␣GC-specific T cells as well as NKT inv cells should be considered in patients receiving ␣GC.
In conclusion, we have demonstrated that specific recognition of CD1d-␣GC complex can be mediated by human V␣24-J␣Q-independent T cell subsets, which use a variety of TCR V␣ and TCR V␤ families. In contrast to conventional NKT inv cells, V␣24-independent T cells are never found in the DN compartment, while they can express CD8 ␣␤ and exhibit CD8 coreceptor-dependent specific cytotoxicity. Furthermore, CD161 is only very rarely expressed by V␣24
Ϫ /CD1d-␣GC-specific T cells expanded in vitro. Finally, the existence of a diverse repertoire of CD1d-␣GC-specific T cells in humans strongly supports their Ag-driven selection. It remains to be assessed whether V␣24-independent CD1d-␣GC-specific T cells are elicited as a result of an adaptive immune response, more similar to MHC/peptide T cell responses, and whether they may have a different physiological role than conventional NKT inv cells.
